VRX Press Releases | Valeant Pharmaceuticals Interna Stock - Yahoo! Finance

Mon, May 20, 2013, 12:33PM EDT - U.S. Markets close in 3 hrs 27 mins

Dow

0.17% Nasdaq

0.12%

More On VRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Valeant Pharmaceuticals International, Inc. (VRX)

-NYSE

77.34 0.83(1.06%) 12:33PM EDT - Nasdaq Real Time Price

Add to Portfolio

Press Releases

Get Press Releases for:

Wednesday, May 15, 2013

Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsCNW Group( (Wed, May 15)
Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsPR Newswire( (Wed, May 15)

Monday, May 13, 2013

Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of ShareholdersCNW Group( (Mon, May 13)
Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of ShareholdersPR Newswire( (Mon, May 13)

Friday, May 10, 2013

Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance ProposalCNW Group( (Fri, May 10)
Valeant Pharmaceuticals International, Inc. Announces Additional Information Regarding Continuance ProposalPR Newswire( (Fri, May 10)

Thursday, May 2, 2013

Valeant Pharmaceuticals Provides Efinconazole UpdateCNW Group( (Thu, May 2)
Valeant Pharmaceuticals Provides Efinconazole UpdatePR Newswire( (Thu, May 2)
Hyperion Therapeutics Exercises Option to Acquire Rights to BUPHENYL(R) and AMMONUL(R)GlobeNewswire( (Thu, May 2)
Valeant Pharmaceuticals Reports 2013 First Quarter Financial ResultsCNW Group( (Thu, May 2)
Valeant Pharmaceuticals Reports 2013 First Quarter Financial ResultsPR Newswire( (Thu, May 2)

Wednesday, May 1, 2013

Actavis Acquires Worldwide Rights for Valeant's Metronidazole 1.3% Vaginal GelCNW Group( (Wed, May 1)